Abstract
Background/Aims HMG-CoA inhibitor (statin) use is a common treatment for elevated cholesterol. Statins are effective in reducing hepatic cholesterol synthesis in prospective studies. Examination of EHR data for estimating statin exposure-time is difficult because prescriptions are in unstructured notes and clinicians prescribe combinations of ‘pill splitting’, while frequently adjusting dosage to keep cholesterol levels under control. Here, we present logic for estimating statin exposure-time based on EHR data.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call